1 – 6 of 6
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2011
- Generalisability of clinical registers used for drug safety and comparative effectiveness research: coverage of the Swedish Biologics Register
- 2009
- Anti-tumour necrosis factor therapy in rheumatoid arthritis and risk of malignant lymphomas:relative risks and time-trends in the Swedish Biologics Register
- 2006
- Swedish registers to examine drug safety and clinical issues in RA
- 2005
- Results from a nationwide postmarketing cohort study of patients in Sweden treated with etanercept
- Risk and case characteristics of tuberculosis in rheumatoid arthritis associated with tumor necrosis factor antagonists in Sweden
- Haematopoietic malignancies in rheumatoid arthritis: lymphoma risk and characteristics after exposure to tumour necrosis factor antagonists